Corealis Pharma will be attending AAPS PharmSci 360, taking place October 25–28, 2026, in New Orleans, Louisiana. As one of the pharmaceutical industry's premier scientific conferences, PharmSci 360 brings together thousands of researchers, formulation scientists, drug developers, manufacturers, and industry leaders to explore the latest advances across formulation, drug delivery, manufacturing, analytical characterization, and translational science.

Attending on behalf of Corealis will be David Leroux-Petersen, David Kwajewski, and Annie Staten. The team looks forward to engaging with pharmaceutical and biotechnology innovators to discuss strategies for overcoming formulation challenges, accelerating development timelines, and advancing oral solid dose programs from early development through GMP clinical manufacturing.

Whether you're developing a complex molecule, exploring bioavailability enhancement approaches, or preparing for clinical studies, Corealis offers the scientific expertise and integrated development capabilities needed to help move your program forward with confidence.

If you'll be attending AAPS PharmSci 360, connect with our team to discuss your development goals and explore how Corealis can support your path from molecule to clinic.